Rhythm Pharmaceuticals Stock Price. Everything You Need To Know About The Rhythm Pharmaceuticals Stock!
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The company is headquartered in Boston, Massachusetts and currently employs 177 full-time employees. The company went IPO on 2017-10-05. The firm is focused on advancing its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) pathway diseases. IMCIVREE is approved by the Food and Drug Administration (FDA) for chronic weight management in adult and pediatric patients six years of age and older with monogenic or syndromic obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1) or leptin receptor (LEPR) deficiency as determined by an FDA-approved test demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS); or Bardet-Biedl syndrome (BBS). The company is evaluating setmelanotide in Phase II and III trials for the treatment of obesity due to variants in one of numerous genes associated with the MC4R pathway.
Rhythm Pharmaceuticals Stock Price. Everything You Need To Know About The Rhythm Pharmaceuticals Stock! performance
- Employees 177
- Company HQ Boston
- Website http://www.rhythmtx.com
- RYTM Asset Type Common Stock
- RYTM Market Capitalization 2.3B
- Earnings Per Share -3.2
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0
Are you interested in investing in Rhythm Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam? Look no further! At Zorion, we provide valuable investment insights and recommendations to retail investors in these countries, enabling them to make informed decisions about their investments. Rhythm Pharmaceuticals is a promising stock that you definitely don’t want to miss out on. As a biopharmaceutical company, Rhythm Pharmaceuticals focuses on developing and commercializing treatments for rare genetic disorders of obesity. By investing in Rhythm Pharmaceuticals, you have the opportunity to support groundbreaking research and potentially reap substantial financial rewards. Wondering how you can invest in Rhythm Pharmaceuticals from Malaysia, Thailand, Indonesia, or Vietnam? Zorion is here to help! Our investment platform offers a seamless and user-friendly experience, allowing you to easily invest in real US stocks and Pre-IPO companies like Rhythm Pharmaceuticals. Additionally, you can access a wide range of educational resources and materials to enhance your investment knowledge. Start your investment journey today and discover the exciting possibilities with Rhythm Pharmaceuticals. Trust Zorion to guide you every step of the way!
